Chat with us, powered by LiveChat
Continuing Education for Pharmacists and Pharmacy Technicians
Pharmacy CE
ACPE Accredited Continuing Education for Pharmacists and Pharmacy Technicians

The Opioid Epidemic: Searching for Solutions Webcast – 1 CE

Activity Overview

According to the 2015 National Survey on Drug Use and Health, approximately 3.8 million people (1.4% of those ages 12 or older) reported misusing prescription pain relievers, while another 329,000 people reported using heroin. Within the same year, 52,404 lethal overdoses took place, making drug overdose the leading cause of accidental death within the United States. Stancliff et al estimated that as of 2012, approximately 80% of people dependent on heroin or prescription opioids were not engaged in any treatment and many in treatment do not use the most effective medication-assisted treatments available to them.

Despite recent increased awareness of opioid use disorder (OUD) and efforts to improve access to care, several barriers to treatment still exist, including financial, geographic, regulatory, and social. In 2012, only 2.2% of physicians in the United States obtained waivers to prescribe buprenorphine for the treatment of OUD. Of those who received waivers, 41.6% were psychiatrists. This may be perceived as a potential barrier to OUD treatment as patients are often resistant to referrals to psychiatric and/or addiction clinics given the stigmas commonly surrounding addiction and mental health. Furthermore, physicians with waivers were found to practice primarily in urban settings, leaving a large portion of the rural population without access to buprenorphine treatment.

With all this in mind, education is needed in regards to current and emerging treatment options for OUD available to multiple patient populations. Also, with the deaths due to drug overdoses still elevated, education on how to recognize and reverse an opioid overdose is needed.

This presentation will address the above needs by discussing the science behind opioid use disorder as well as reflect upon current statistics associated with its impact on the United States. During the discussion, opioid overdose risks will be discussed and participants will be able to practice recognizing key symptoms of an overdose situation. Steps of using naloxone will be discussed and connected to how to appropriately seek out treatment for maintenance of opioid use disorder. Finally, new buprenorphine products and the potential role of naltrexone will be applied to this stigmatized population.

Pharmacist and Physician Learning Objectives

At the conclusion of this continuing education activity, the participant will be able to:

  1. Discuss the pertinent nature of opioid use/abuse throughout the United States
  2. Describe how to recognize and treat an opioid/heroin overdose
  3. Describe currently indicated pharmacologic treatment options for opioid withdrawal, detoxification, and maintenance, including new agents now on the market
  4. Identify and discuss new treatment options for opioid use disorder

Pharmacy Technician and General Learning Objectives

At the conclusion of this continuing education activity, the participant will be able to:

  1. Discuss the pertinent nature of opioid use/abuse throughout the United States
  2. Describe how to recognize and treat an opioid/heroin overdose
  3. Describe risks associated with an opioid/heroin overdose
  4. List current and upcoming treatment options for opioid use disorder

     BUY NOW

Accreditation Statement

ACPEAchieveCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. AchieveCE is also accredited by the Florida Board of Pharmacy (provider no. 50-20641). This course is approved by CE Broker, with CE Broker No. 20-846427.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Continuing Education Company, Inc. and AchieveCE. Continuing Education Company, Inc. is accredited by the ACCME to provide continuing medical education for physicians.

Continuing Education Company, Inc. designates this enduring material for a maximum of 1 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AchieveCE is accredited through the Academy of General Dentistry (AGD) with provider ID #386503

AchieveCE is also an accredited provider by the Florida Board of Nursing (Provider #50-20641) and the California Board of Registered Nursing (CEP17265), and is an approved provider through reciprocity for the states of Arkansas, District of Columbia, Georgia, Kentucky, New Mexico, South Carolina, and West Virginia.

Faculty Information

Bennett Doughty, PharmD, BCPS, BCPP earned his Doctor of Pharmacy degree from the University of Connecticut School of Pharmacy in 2016. Following graduation, Doughty completed two years of residency training at the VA Connecticut Healthcare System in West Haven, Conn., specializing in psychiatric pharmacy.

Financial Support Disclosure

This activity was developed by AchieveCE free of any commercial support. Bennett Doughty, PharmD, BCPS, BCPP, faculty for this educational event, has no relevant financial relationship(s) with ineligible companies to disclose. Jaimini Patel, RPh, and Pete Kreckel, RPh, planners for this educational event, also have no relevant financial relationship(s) with ineligible companies to disclose.

Content Complexity

  Level 2. Basic Application of Skills and Concepts

Delivery Type

Home Study Webcast

}

Credits

1.0 Contact Hour

Category

Substance Abuse
Disease State Management/Drug Therapy

Target Audience

Dental Professional
Medical Psychologist
Mental Health Professional
Midwife
Nursing Professional
Osteopathic Doctor
Pharmacist
Pharmacy Technician
Physician
Physician Assistant
Podiatric Physician

Activity Type

Knowledge-based

Universal Activity Number

Pharmacist: 
0657-0000-21-071-H01-P
Pharmacy Technician:
0657-0000-21-071-H01-T

Pharmacy Activity Release Date

July 14, 2021

Pharmacy Activity Expiration Date

July 14, 2024

ACCME Activity Number

201836988

ACCME Expiration Date

February 15, 2023

Cost

$15.00

Handout Download Link(s)

Already a Member?

Requirements for Credit

Participants must score a passing grade of 70% or higher on the activity post-test and complete an activity evaluation. There are no time limits and unlimited test-taking attempts. Credits will be reported automatically to CPE Monitor and/or CE Broker if your license information is entered properly in your profile.

CE Broker Reporting

If you are licensed under a board supported by CE Broker, feel free to log into your CE Broker account to view your reported courses or to contact their support staff.

Hardware Requirements

Windows 8.1, Windows 10
Mac OS X 10.1 or higher
iOS 10+, Android 4.3+

Software Requirements

Google Chrome, Microsoft Edge, Mozilla Firefox
Adobe Acrobat Reader

Network Requirements

Broadband Internet Connection:
T1, Hi-speed DSL or Cable
4G cellular connection

Get Unlimited CE!

Get unlimited CE for one low annual fee.
Save time and money by becoming a member!

Need more Pharmacy CEs?

Check out other live webinars and home study activities to study at your own time!